Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

NCT00561704 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Obese
Type 2 Diabetes
Diabetic Nephropathy
Glucose Metabolism
Angiotensin II Type 1 Receptor Blockers

Interventions

DRUG: losartan

Sponsor

Shanghai Jiao Tong University School of Medicine